Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Cybin Completes Reverse Take-Over Transaction | Business Wire
Cybin Corp Announces Partnership with the Toronto Centre for ...
Cybin Pf Inj 100mg/ml in Mumbai, VHB Life Science Ltd. | ID: 9813191230
Cybin Corp: Developing Psychedelic Medicines and Nutraceutical Products ...
Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic ...
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1 ...
Cybin Announces Publication in Frontiers in Psychology Journal ...
Cybin Announces Positive Topline Data from Phase 1 Studies of ...
CYBIN - Cybin Corp. Trademark Registration
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and ...
Cybin Therapeutics 2025 Company Profile: Valuation, Funding & Investors ...
Cybin Announces Approval of First-in-Human Dosing of its Proprietary ...
Cybin has partnered with Worldwide Clinical Trials — a global, full ...
Ethical Biopharmaceutical Company Cybin Establishes Presence in St ...
Cybin (CYBN.NE) Completes 51st Pre-Clinical Psychedelic Molecule Study ...
Cybin Announces Successful Completion of In Vivo Preclinical Studies ...
Cybin Acquires DMT Clinical Study from Entheon Biomedical. The Phase 1 ...
Cybin Receives FDA Breakthrough Therapy Designation for its Novel ...
Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
Cybin Announces Changes to Lead Buildout of Clinical Capabilities - AI ...
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating ...
Cybin Announces First Patient Dosing in Psilocybin Depression Clinical ...
Cybin | Tendril
FDA Grants Cybin Breakthrough Therapy Designation for CYB003 - The ...
Cybin (CYBN.NEO) approved for first-in-human dosing - Equity.Guru
Cilo Cybin Holdings Announces Acquisition of Cilo Cybin Pharmaceutical ...
Cybin to Measure Psychedelic Effects on the Brain | Psychedelic Spotlight
Cybin receives FDA approval for new in-human clinical trial ...
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 ...
Cybin Raises $150M to Advance Psychedelic Therapy for Depression
Cluster Buying Signals Insider Confidence as Cybin Inc Advances in ...
Cybin Announces Groundbreaking Clinical Progress, Unveiling ...
How Cybin Is 'Revolutionizing' Healthcare with Psychedelic Compounds
Cybin Receives FDA Breakthrough Therapy Designation - Long Term Biotech ...
Cybin Phase 3 Trial Advances as FDA Prioritizes Psychedelic Reviews ...
Extremely proud of how the Cybin Inc. team has been able to leverage an ...
Cybin Major Depressive Disorder Phase 2 | Nurse Sarah Barker
Cybin reports positive results after CYB003 dose | Cybin Inc posted on ...
Cybin Enters Definitive Agreement To Acquire Small Pharma | IBTimes
Cybin Corp. and IntelGenx Corp. Enter Into Feasibility Agreement for ...
Cilo Cybin Holdings Sitting on R60m; Shareholders Now Waiting for the ...
Patent Granted for Cybin Anxiety Drug CYB004 as Phase 2 Trial Advances ...
Cybin Teams With Thermo Fisher for Phase 3 Manufacturing | Technology ...
Cybin plans to run four clinical trials in 2024 | Cybin Inc posted on ...
Drysdale Explains $30m Cybin Shares Purchase Agreement - The Dales Report
Worldwide Clinical partners with Cybin for psychedelic-based treatments ...
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in ...
Cybin Leads in Aligning with FDA's New Psychedelic Drugs Guidelines: A ...
Cybin Inc. Stock Overview — CYBN Summary & Analysis — Roic AI
Cybin Moves Forward With Market Strategies for Expansion Into ...
Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program ...
Cybin closes acquisition of Small Pharma | Cybin Inc posted on the ...
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To ...
Catalent partners with Cybin for Fast-Dissolve Formulation CYB003
Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough ...
Cybin R&D Day: Innovating New Treatment Approaches for Mental ...
Cybin Careers | Levels.fyi
Cybin enrolls in CYB003 study | Cybin Inc posted on the topic | LinkedIn
Join Cybin tomorrow at the 6th Annual Neuropsychiatric Drug Development ...
FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain
Cybin Tackles Major Depressive Disorder with Psychedelic-Based ...
Let's not forget about Cybin pipeline and the amazing team they have ...
Cybin ($CYBN) Announces Advancement in DMT Therapies with First Human ...
Cybin Announces Promising Results from Feasibility Study Measuring ...
Cybin grants two U.S. patents for tryptamine-based drugs | Cybin Inc ...
Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring ...
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic ...
Cybin to Acquire Small Pharma Inc.
CybinInc on Twitter: "#BreakingNews Cybin Acquires DMT Clinical Study ...
Cybin Inc. - Prism MarketView
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E ...
Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is ...
Cybin Therapeutics - LifeScienceHistory.com
Cybin Outlines Upcoming Priorities and Milestones for its Clinical ...
The Top Companies Leading Psilocybin Research & Therapy
List of Biotech, Pharmaceutical & Life Sciences companies in Canada
Cybin's CYB003 Receives UK Approval for Phase 3 Study on Depression ...
Cybin's Psilocybin Program Granted FDA Breakthrough Designation
CybinInvestorsClub
CYB003 psilocybin analog earns FDA breakthrough status
加拿大临床阶段生物制药公司：Cybin Inc. (CYBN) | 美股之家 - 港股美股开户投资百科全书
julioviskovich - julioviskovich
UK Approves Cybin's Phase 3 Depression Treatment Trial Across 60 Global ...
Former Director of Psychiatric Products at FDA Joins Psychedelic Life ...
More positive news for patients & Cybin, as we seek to bring new ...
Cilo Cybin: Personalized Healthcare Solutions, Medical Cannabis ...
A Guide to Their Uses and Benefits Of Soulcybin
Psychedelic News Roundup: Half The World Faces Mental Health Crisis
Psychedelic Vantage | Covering Psychedelic Drug Development, Education ...
Cybin’s Sublingual Psilocybin Strips Head to Clinical Trials for Dose ...
Paul F. Austin - Microdosing Psychedelics Coach
Psychedelic treatment breakthrough: Cybin’s CYB003 gives hope to ...
How to Invest in Psychedelics 101 | EDGE Investments
